AEON Biopharma, Inc.
AEON
$0.24
$0.001.19%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3,238.81% | -135.54% | -193.37% | -100.02% | 99.46% |
| Total Depreciation and Amortization | -10.34% | -14.29% | -19.59% | -17.35% | -13.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 530.05% | 126.04% | 145.61% | 73.41% | -103.51% |
| Change in Net Operating Assets | 106.61% | 103.63% | -1,083.14% | 36.95% | 67.91% |
| Cash from Operations | -0.49% | 38.60% | 14.71% | 56.93% | 68.72% |
| Capital Expenditure | 100.00% | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 100.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -85.82% | -90.09% | 12,494.56% | 37,122.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -53.52% | -72.51% | 34.05% | 23.66% | 23.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.22% | -147.29% | 158.17% | 134.46% | 117.60% |